Morgan Stanley’s Gelteq Ltd GELS Stock Holding History

Morgan Stanley’s Portfolio GELS Stock Details GELS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.1K	Buy	+15,000	New	+$9.63K	﹤0.01%	7046
2025 Q4	–	Sell	-651	Closed	-$898	–	8533
2025 Q3	$898	Buy	+651	New	+$1.01K	﹤0.01%	7396
2025 Q2	–	Sell	-3,500	Closed	-$3.64K	–	8318
2025 Q1	$3.64K	Buy	+3,500	New	+$6.55K	﹤0.01%	7067

Other funds holding GELS

TSS

Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Morgan Stanley's GELS Position: Q2 2026 in Review

Morgan Stanley opened a new position in Gelteq Ltd (GELS) in Q2 2026: 15,000 shares worth $10.1K. The stake represents ﹤0.01% of the portfolio and ranks #7046 among its holdings. This is a return to the name: Morgan Stanley previously reported a position in GELS as recently as Q3 2025.

Morgan Stanley first reported a position in GELS in Q1 2025 and has held it in 3 quarters since. 6 funds tracked by Wall St. Rank hold GELS as of Q2 2026.

Morgan Stanley held 15,000 shares of Gelteq Ltd worth $10.1K as of Q2 2026.
Gelteq Ltd was a new Morgan Stanley position in Q2 2026.
Gelteq Ltd made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #7046 holding.
Morgan Stanley first reported a position in Gelteq Ltd in Q1 2025 and has held it in 3 quarters since.
6 funds tracked by Wall St. Rank held Gelteq Ltd as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.